Advertisement

Topics

SK Capital Continues to Invest in Archroma

03:00 EDT 17 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
New Investment Aimed to Support the Company’s Growth and Potential Industry Consolidation SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceutical sec...

Other Sources for this Article

For Archroma:
Muriel Werlé, +41 61 716 3375 or +41 79 536 9117
muriel.werle@archroma.com
or
For SK Capital:
Philip Nunes, 617-391-0792
phil.nunes@backbaycommunications.com

NEXT ARTICLE

More From BioPortfolio on "SK Capital Continues to Invest in Archroma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...